Patents by Inventor Susan L. Way

Susan L. Way has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20240050376
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: October 17, 2023
    Publication date: February 15, 2024
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, JR., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20220323362
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: November 19, 2021
    Publication date: October 13, 2022
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, JR., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20210338590
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: July 13, 2021
    Publication date: November 4, 2021
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, JR., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20210085614
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: December 4, 2020
    Publication date: March 25, 2021
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, Jr., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20200253880
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: March 23, 2020
    Publication date: August 13, 2020
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, JR., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20200108016
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: April 6, 2017
    Publication date: April 9, 2020
    Applicant: Acorda Therapeutics, Inc.
    Inventors: Joseph E. Cobb, JR., Thomas B. Gold, Rohini D'Souza, Susan L. Way
  • SUSTAINED RELEASE COMPOSITIONS OF 4-AMINOPYRIDINE
    Publication number: 20180344649
    Abstract: The present invention generally relates to sustained release 4-aminopyridine tablets, which include a core and a coating. The sustained release tablets of the invention are generally suitable for once daily oral administration for the treatment of neurological disorders.
    Type: Application
    Filed: September 28, 2016
    Publication date: December 6, 2018
    Inventors: Joseph E. Cobb, Jr., Thomas B. Gold, Rohini D'Souza, Susan L. Way